Daniel A Ruiz-Torres1,2,3, Michael E Bryan1,2, Shun Hirayama1,2

  • 1Department of Otolaryngology-Head and Neck Surgery, Harvard Medical School, Boston, MA 02115, USA.

概括

三级淋巴细胞结构 (TLS) 在响应免疫检查点阻塞 (ICB) 的头支状细胞癌 (HNSCC) 患者中更为普遍. TLS密度预测了ICB反应和生存,可能会超过PD-L1综合阳性得分 (CPS).